SharonL.GardnerMD

Clinical Trials

• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer Start of enrollment: 2000 Oct 01

  Completed

  Phase 1

• Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma Start of enrollment: 2003 Nov 01

  Completed

  Phase 2, Phase 3

• High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas Start of enrollment: 2004 Oct 01

  Completed

  Phase 3

• Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors Start of enrollment: 2005 Oct 01

  Completed

  Phase 2

• Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CNS Tumors Start of enrollment: 2009 Jul 01

  Completed

  Phase 1

• Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) Start of enrollment: 2011 Sep 01

  Terminated

  Phase 2

• ONC201 in Pediatric H3 K27M Gliomas Start of enrollment: 2018 Jan 29

  Active, not recruiting

  Phase 1

  Roles: Principal Investigator, Contact

• Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

  Available

  Roles: Contact, Principal Investigator

• HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors Start of enrollment: 2015 Sep 01

  Active, not recruiting

  Phase 4

  Roles: Contact

• Join now to see all